News
I delivered a talk at the 4th annual Law and Antisemitism conference held at the UCLA School of Law. At a time when the Trump ...
12hon MSN
A woman will avoid jail time after investigators say she vandalized multiple cars of pro-Palestinian protestors outside of an ...
The pro-Israel New York congressman denounces protester detentions and faces blowback from former funders who are aiding them ...
The report found more than 1,000 hate incidents over the past five years. Twenty-six Illinois counties had at least six hate incidents each, including Coles, Macon, McLean and Rock Island counties.
The report found more than 1,000 hate incidents over the past five years. Twenty-six Illinois counties had at least six hate incidents each, including Coles, Macon, McLean and Rock Island counties.
Inebilizumab, a first-in-class CD19+ B-cell–targeting agent, is safe and effective for up to 1 year in patients with generalized myasthenia gravis, a phase 3 trial suggests.
1d
MedPage Today on MSNBenefits in Myasthenia Gravis Extend to 52 Weeks With InebilizumabInebilizumab (Uplizna) improved function and reduced disease severity for up to 52 weeks in generalized myasthenia gravis ...
ILLINOIS ( 25News Now) - A new report from the Anti-Defamation League says that hate and extremism incidents are up ...
Hate leafleting has become an increasingly common means for extremist groups to espouse hateful messages and intimidate ...
Autoimmune generalized myasthenia gravis is a disease that manifests with fluctuating muscle weakness. Inebilizumab is a ...
The randomized control period of the MINT trial has completed, and these newest data describe outcomes among patients who ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results